Login

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma 00:00:00

Share On Facebook Share On Twitter

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
How Project 44 and Amber Road Add More Value for Their Clients | Andrew Appel, Chief Executive Officer, Amber Road Inc AMBR:NYQ
00:00:00
Care Options for Facial Reanimation - Elizabeth A. Bradley, M.D. Ophthalmologist, Mayo Clinic
00:10:00
Xylem's Patrick Decker and Evoqua's Ron Keating, CEOs of water technology firms, discuss the implications of a $7.5 billion deal.
00:10:00
MicroStrategy CEO Michael Saylor shares insights on the future of the company.
00:10:00
Challenges and Opportunities in Today's Investment Landscape | Abel Sithole, CEO , Public Investment Corporation.
00:10:00
Advancements in Millimeter Wave Technology for High-Speed Wireless Solutions | Ron Glibbery, CEO, Peraso Inc.
00:10:00
Jonas Wiström on Ratos's Q1 2022 Performance | Jonas Wiström, CEO, Ratos.
00:10:00
The Deal Economy - CEO Sam Riley | Sam Riley, CEO, Ansarada Group LtdAND:ASX
00:10:00
AboitizPower CEO Manny Rubio discusses navigating the company through the pandemic and investing in renewable energy.
00:10:00
Morgan Stanley CEO Transition: James Gorman and Ted Pick on Leadership and the Future
00:10:00
Accelerating Energy Transition: Javier Div's Commitment to Collaboration and Sustainability | Javier Dib , CEO, AES Andes SA.
00:10:00
Medtech Meltdown: Can Healthcare Innovation Weather a VC Storm|Amy Cheetham,Partner,Costanoa Ventures

© 2017 - Neuhu+